Patients with acute myeloid leukemia (AML) and hematopoietic cell transplant recipients with granulocytopenia
Care Setting
Hematology/oncology and transplant centers with blood transfusion capabilities
Key Highlights
Granulocyte transfusions have been studied for over 50 years but remain controversial due to inconsistent evidence of safety and efficacy.
Randomized controlled trials showed no improvement in infection incidence, remission rate, or survival with prophylactic granulocyte transfusions in AML patients.
Risks include transfusion reactions, allo-immunization, pulmonary complications, and negative interactions with antifungal agents like amphotericin.
Guideline-Based Recommendations
Diagnosis
Monitor blood granulocyte concentration to identify patients at increased infection risk (<0.5 × 10^9/L).
Assess bone marrow recovery status as a key determinant of infection outcome.
Management
Avoid routine prophylactic granulocyte transfusions during remission-induction chemotherapy in AML due to unfavorable risk-benefit profile.
Consider granulocyte transfusions cautiously and selectively, recognizing limited evidence of benefit.
Use effective systemic and oral antibiotics and antifungal prophylaxis to reduce infection risk.
Monitoring & Follow-up
Monitor for transfusion reactions and pulmonary complications during granulocyte transfusions.
Screen for allo-immunization to HLA and granulocyte-specific antigens which may reduce transfusion efficacy.
Risks
High rates of transfusion reactions and allo-immunization.
Potential sequestration of transfused granulocytes in lungs compromising pulmonary function.
Adverse interactions with antifungal agents such as amphotericin.
Patient & Prescribing Data
Patients with AML undergoing intensive induction chemotherapy and hematopoietic cell transplant recipients with granulocytopenia
Granulocyte transfusions have not demonstrated clear benefit in reducing infections or improving survival; their use has declined due to associated risks and lack of efficacy.
Clinical Best Practices
Prioritize antimicrobial prophylaxis and supportive care over granulocyte transfusions for infection prevention in granulocytopenic patients.
Reserve granulocyte transfusions for select cases where benefits may outweigh risks, with careful monitoring.
Engage multidisciplinary teams including transplant, transfusion, and blood bank experts when considering granulocyte transfusions.
Recognize bone marrow recovery as the critical factor for infection resolution rather than granulocyte transfusions alone.
Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.
